Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that fat tissue in the skin is a new finding in Frontal fibrosing alopecia and may contribute to hair follicle and muscle degeneration.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.

Inhibiting connective tissue sheath contraction may improve hair growth in male pattern baldness.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

Terminalia chebula fruit extract helps hair growth by reducing DHT and boosting hair cell activity.

Hair loss in males and females is influenced by immune cell interactions, with potential treatments identified.

Smoking increases the risk and severity of male pattern baldness.

Estrogen affects hair growth, and GPER-1 levels might help identify hair loss types.

Understanding hair growth pathways can lead to better hair loss treatments.

Bicalutamide shows promise for treating female hair loss.

Combining fractional CO2 laser with topical dutasteride is more effective for treating male hair loss than using the laser alone.

Severe hair loss may increase the risk of dying from COVID-19.

Serum IMA levels don't help diagnose AGA but may indicate its severity.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Higher alarin levels might link hair loss and metabolic syndrome.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.

AGA is caused by genetics and androgens, treatable with finasteride and minoxidil.

Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

Finasteride reduces hair follicle cell death in androgenetic alopecia.

Botulinum toxin A does not significantly improve hair density or thickness in androgenetic alopecia.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.